Key facts
- Notable investors include MedTech Innovator, National Institutes of Health, Matter (Consulting Services (B2B)), Catalyst by Wellstar, Femovate — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Armor Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Armor Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Armor Medical
Developer of a hemorrhage detection device designed to prevent bleeding in women. The company has developed a light-based, wrist-worn device designed to monitor and detect severe bleeding, or hemorrhage, after giving birth, which can happen in minutes, hours, or days after birth, enabling healthcare institutions in real-time monitoring to enhance patient outcomes and reduce healthcare costs.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2022
- Employees
- 5
- Website
- armormedical.us/
- Ownership
- Privately Held (backing)
Armor Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Armor Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Armor Medical in its N-PORT filings yet. We sweep new filings monthly.